Anti-N-epsilon acetyl Lysine antibody [11A1] (ab409)

Publishing research using ab409? Please let us know so that we can cite the reference in this datasheet.

ab409 has been referenced in 8 publications.

  • Peng Y  et al. Deficient import of acetyl-CoA into the ER lumen causes neurodegeneration and propensity to infections, inflammation, and cancer. J Neurosci 34:6772-89 (2014). PubMed: 24828632
  • Ding Y  et al. Biochemical Inhibition of the Acetyltransferases ATase1 and ATase2 Reduces ß-Secretase (BACE1) Levels and Aß Generation. J Biol Chem 287:8424-33 (2012). WB . PubMed: 22267734
  • Pehar M  et al. Proteomic assessment shows that many ER-resident proteins are targeted by N{varepsilon}-lysine acetylation in the lumen of the organelle and predicts broad biological impact. J Biol Chem : (2012). WB . PubMed: 22628546
  • Guo B  et al. Dynamic modification of the ETS transcription factor PEA3 by sumoylation and p300-mediated acetylation. Nucleic Acids Res 39:6403-13 (2011). WB . PubMed: 21543453
  • Choi JK  et al. Acetylation of Rsc4p by Gcn5p is essential in the absence of histone H3 acetylation. Mol Cell Biol 28:6967-72 (2008). WB . PubMed: 18809572
  • Costantini C  et al. A reversible form of lysine acetylation in the ER and Golgi lumen controls the molecular stabilization of BACE1. Biochem J 407:383-95 (2007). WB . PubMed: 17425515
  • Mantovani F  et al. The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP. Nat Struct Mol Biol 14:912-20 (2007). PubMed: 17906639
  • Mantovani F  et al. Pin1 links the activities of c-Abl and p300 in regulating p73 function. Mol Cell 14:625-36 (2004). PubMed: 15175157

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"